Coronavirus Latest News

Coronavirus: Chinese media champion Sinovac’s vaccine but not everybody is convinced

When Brazilian researchers announced lower-than-expected phase 3 results for a Chinese coronavirus vaccine clinical trial, the response was swift.Various regulators around the world said they would take a close look at the data for Sinovac Biotech’s CoronaVac product, which the company’s Brazilian partner, the Butantan Institute, said on Tuesday had a roughly 50 per cent general efficacy rate – well below the 78 per cent reported earlier.But there was little mention in Chinese media on Thursday…

Read the original article at South China Morning Post

Related Articles

Back to top button